EU drug companies warn of exodus to US as Trump threatens import tariffs Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’ The Guardian - UK · Apr 9, 2025
China, America and pay inject drama into AstraZeneca’s AGM The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year The Guardian - UK · Apr 6, 2025
Painkillers without the addiction? The new wave of non-opioid pain relief Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced The Guardian - UK · Apr 5, 2025
Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’ Rare admonition from a sector that has largely been silent in the face of the second Trump administration The Guardian - US · Mar 30, 2025
Potential threat of US tariffs ‘not as stark’ as 2008 crash – Irish minister Enterprise Minister Peter Burke said pharma tariffs could be ‘a double-edged sword’ for the US administration. Evening Standard · Mar 30, 2025
Why are users of 23andMe being urged to delete their data? Genetic testing company’s bankruptcy proceedings could result in auction of the genetic data of 15 million users. Al Jazeera · Mar 26, 2025
Banks drag back early gains as local shares edge higher The Australian share market has given up more than half its early session gains but finished slightly higher, after a dramatic about-face in financials stocks. AAP · Mar 25, 2025
Man who claimed Roundup caused his cancer awarded $2.1billion The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide The Independent UK · Mar 23, 2025
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion The Guardian - UK · Mar 21, 2025
UK pharmacies could cut hours unless NHS provides ‘new and sufficient’ funding The National Pharmacy Association has recommended collective action for the first time in its history The Guardian - UK · Mar 18, 2025
AMD manager reports 45% GPU retail market share in Japan — Eyes 70% as the next target AMD marketing manager Yoshiaki Sato reported that Radeon GPUs have accounted for 45% of GPU sales in Japan, presumably since RDNA 4 launched. Tom’s Hardware · Mar 17, 2025
AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’ UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug The Guardian - UK · Mar 17, 2025
Ireland could lose pharma tax to US after Trump accusations, experts warn Predictions that US firms could retain manufacturing plants in Ireland but move profits back to America The Guardian - UK · Mar 13, 2025
CVS is opening more standalone pharmacies after shuttering 1,000 stores CVS will open a dozen new stores, but they’ll be half the size of a typical location The Independent UK · Mar 10, 2025
Tom’s Hardware · Mar 10, 2025 Raspberry Pi powers briefcase-sized PiEEG 'Bio Lab' project Blink twice to control the robot arm
Evening Standard · Mar 6, 2025 Why neurohacking is the new biohacking Brain training just got an upgrade: neurohacking is the latest wellness microtrend, but is there a way to do it without breaking the bank?
Latin Times · Mar 2, 2025 Marjorie Taylor Greene Claims 'Bio Labs' in Ukraine Are Using 'Dr. Frankenstein Science' to Create Diseases and Vaccines Rep. Marjorie Taylor Greene weighed in on a mystery disease outbreak, suggesting global bio labs, including in Ukraine, are sinisterly engineering diseases.
Windows Central · Mar 1, 2025 Skip NVIDIA — Why AMD’s new gaming GPU is my next upgrade, and why it should be yours, too AMD revealed its next-gen RDNA 4 graphics cards, and the info available so far is enough for me to make a final decision on my next PC upgrade.
The Guardian - UK · Feb 28, 2025 British pharma company GSK pauses diversity work citing Trump orders London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market
The Guardian - UK · Feb 26, 2025 Covid inquiry to hear evidence about Michelle Mone-linked firm in private Chair rules that details about PPE contracts given to company linked to Tory peer will be heard in closed session
The Independent UK · Feb 25, 2025 The war on kush: The synthetic drug sweeping through parts of Africa A new report by an anti-transnational crime group has identified the core chemical components of kush, a synthetic drug that has swept through Sierra Leone and the region in the past few years.
The Independent UK · Feb 25, 2025 The Latest: Musk renews threat to fire federal workers despite pushback from various agencies Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they accomplished last week
Dynamite News · Feb 25, 2025 Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine, with the option to transfer the drug substance process at a later stage. Read further on Dynamite News:
Evening Standard · Feb 25, 2025 Why has Unilever CEO Hein Schumacher stepped down and who is replacing him? Mr Schumacher was named CEO in 2023 following the retirement of Alan Jope but has now stepped down in a surprise move
StockNews.com · Feb 24, 2025 3 Pharmaceutical Stocks With Blockbuster Drug Potential The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors might consider adding three well-positioned biotech stocks such as Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN), and Gilead Sciences (GILD), for potential gains. Learn more….